By identifying relevant microscopic patterns across large image patches, new AI models can process the immense complexity of whole slide images much faster than manual human observation. Modern computational pathology is undergoing a radical transformation as deep learning architectures move beyond
Securing a regulatory green light for the Phase 2b trial design ensures that the data generated will meet the rigorous standards required by the United States Food and Drug Administration. This development represents a monumental shift for Syntara Limited, a Sydney-based biotechnology firm that has
Ivan Kairatov is a seasoned biopharma expert whose career has been defined by a front-row seat to the evolution of targeted oncology. With deep roots in research and development and a keen eye for technological innovation, he has helped navigate the complex intersection of clinical necessity and
The clinical research industry is currently weathering a transformative storm where the sheer velocity of data collection frequently outpaces the logistical capacity of the human teams working on the front lines of patient care. While high-level financial metrics suggest an unprecedented era of
The traditional landscape of pharmaceutical development often leaves academic institutions as mere suppliers of raw intellectual property rather than central players in the multi-billion-dollar drug manufacturing process. For years, the University of Alabama at Birmingham has functioned as a
The quest to match the right cancer therapy with the right patient has long been hindered by the unpredictable nature of how individual tumors behave within the human body. Researchers at the University of California, San Francisco have recently introduced a transformative approach to oncology by
